Although there is no complement alternative pathway-related abnormalities described, the severe renal injury and normal ADAMTS13 are reminiscent of HUS, in which complement blockade is remarkably efficient [10]. The gene discussed is ADAMTS13; the disease is hemolytic-uremic syndrome.